Rankings
▼
Calendar
SCLX (Scilex Holding Company) Stock Financials & Earnings | Market Cap Arena
SCLX
Scilex Holding Company
Mkt Cap
$73M
Healthcare
·
Drug Manufacturers - General
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$40M
Net Income (TTM)
-$376M
EPS (TTM)
-$33.08
Free Cash Flow (TTM)
$24M
Gross Margin
68.6%
Op. Margin
-652.4%
Net Margin
-931.2%
FCF Margin
59.0%
P/S Ratio (TTM)
1.8x
P/E Ratio (TTM)
—
YoY Rev Growth
-26.8%
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$12M
$7M
-$20M
Q1 23
$11M
$7M
-$25M
Q2 23
$13M
$8M
-$23M
Q3 23
$10M
$7M
-$39M
Q4 23
$13M
$8M
-$18M
Q1 24
$11M
$7M
-$19M
Q2 24
$16M
$12M
-$16M
Q3 24
$14M
$11M
-$20M
Q4 24
$15M
$10M
-$28M
Q1 25
$5M
$4M
-$28M
Q2 25
$10M
$7M
-$21M
Q3 25
$11M
$7M
-$187M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
1.9x
—
Q1 23
1.8x
—
Q2 23
1.6x
—
Q3 23
1.6x
—
Q4 23
1.6x
—
Q1 24
1.6x
—
Q2 24
1.4x
—
Q3 24
1.3x
—
Q4 24
1.3x
—
Q1 25
1.4x
—
Q2 25
1.7x
—
Q3 25
1.8x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$19M
-$19M
Q1 23
-$8M
-$8M
Q2 23
-$13M
-$13M
Q3 23
$6M
$6M
Q4 23
-$5M
-$6M
Q1 24
$9M
$9M
Q2 24
$2M
$2M
Q3 24
$5M
$5M
Q4 24
$3M
$2M
Q1 25
$6M
$6M
Q2 25
$7M
$7M
Q3 25
$8M
$9M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$7K
Q1 23
$0
Q2 23
$0
Q3 23
$155K
Q4 23
$299K
Q1 24
$150K
Q2 24
$150K
Q3 24
$150K
Q4 24
$150K
Q1 25
$150K
Q2 25
$4
Q3 25
$300K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
+44.2%
+69.5%
Q1 23
+55.3%
+130.9%
Q2 23
+58.7%
+82.5%
Q3 23
-11.1%
+122.4%
Q4 23
+12.9%
+0.4%
Q1 24
+2.9%
-15.8%
Q2 24
+30.1%
-9.6%
Q3 24
+42.7%
-29.8%
Q4 24
+10.7%
+36.1%
Q1 25
-54.0%
+8.4%
Q2 25
-39.5%
-5.0%
Q3 25
-26.8%
+473.7%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$0
0.0%
Q1 23
$4M
35.2%
Q2 23
$4M
28.5%
Q3 23
$4M
34.7%
Q4 23
$4M
28.1%
Q1 24
$4M
32.7%
Q2 24
$4M
22.1%
Q3 24
$4M
26.1%
Q4 24
$5M
32.2%
Q1 25
$3M
66.2%
Q2 25
$3M
33.1%
Q3 25
$3M
30.8%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q4 22
$3M
$16M
$7M
—
Q1 23
$3M
—
—
$29M
Q2 23
$3M
—
—
$27M
Q3 23
$4M
—
—
$40M
Q4 23
$3M
—
—
$24M
Q1 24
$3M
—
—
$29M
Q2 24
$2M
—
—
$25M
Q3 24
$2M
—
—
$30M
Q4 24
$2M
—
—
$35M
Q1 25
$2M
—
—
$28M
Q2 25
$6M
—
—
$20M
Q3 25
$4M
—
—
$189M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$2M
$0
$2M
Q1 23
$5M
$0
$5M
Q2 23
$34M
$0
$34M
Q3 23
$2M
$0
$2M
Q4 23
$4M
$0
$4M
Q1 24
$2M
$0
$2M
Q2 24
$7M
$0
$7M
Q3 24
$77K
$0
$77K
Q4 24
$3M
$0
$3M
Q1 25
$6M
$0
$6M
Q2 25
$4M
$0
$4M
Q3 25
$878K
$0
$878K
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
4M
+0.7%
Q1 23
4M
+5.5%
Q2 23
4M
+0.7%
Q3 23
4M
-2.0%
Q4 23
4M
-3.4%
Q1 24
4M
-5.5%
Q2 24
3M
-5.8%
Q3 24
4M
+5.6%
Q4 24
7M
+91.6%
Q1 25
12M
+66.4%
Q2 25
12M
+0.3%
Q3 25
12M
+0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 19
—
—
FY 20
—
—
FY 21
—
—
FY 22
$257K
148
FY 23
$445K
105
FY 24
$492K
115
marketcaparena.com